Zeria Pharmaceutical (4559.T) Earnings Analysis
Zeria Pharmaceutical (4559.T) next reports earnings on 2026-08-06. Trailing P/E 10.89.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 4559.T next report earnings?
| Next earnings date | 2026-08-06 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | 21.60B |
4559.T earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-08 | 65.8 JPY | n/a | n/a | n/a |
| 2026-02-05 | 86.58 JPY | n/a | n/a | n/a |
| 2025-02-05 | 49.12 JPY | n/a | n/a | n/a |
| 2024-08-01 | 95.57 JPY | n/a | n/a | n/a |
4559.T valuation and analyst view
| Trailing P/E | 10.89 |
|---|---|
| Trailing EPS | 191.8 JPY |
| Price / book | 0.85 |
| Dividend yield | 2.35% |
| Market cap | 92.92B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Zeria Pharmaceutical (4559.T)'s next earnings date?
Zeria Pharmaceutical is next scheduled to report on 2026-08-06 and revenue estimate of 21.60B.
Did 4559.T beat earnings last quarter?
Consensus estimate data was not available for 4559.T's 2026-05-08 report.
What is 4559.T's current P/E ratio and EPS?
4559.T trades at a trailing P/E of 10.89 on trailing EPS of 191.80432859184646 JPY.
What do analysts rate 4559.T?
4559.T has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.